Construction of mouse podocyte clone-5 cell lines with <i>Smad3</i> knockout by CRISPR/Cas9.

Xiu YANG; Jiangshan SHI; Honglian WANG; Li WANG; Hongwei SU; Chen CHEN; Changying ZHAO

Return

Construction of mouse podocyte clone-5 cell lines with Smad3 knockout by CRISPR/Cas9.

Author: Xiu YANG ¹ ; Jiangshan SHI ¹ ; Honglian WANG ² ; Li WANG ² ; Hongwei SU ² ; Chen CHEN ² ; Changying ZHAO ²
Author Information

1. College of Integration of Traditional Chinese and Western Medicine to Southwest Medical University, Luzhou 646000, Sichuan, China.
2. The Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Luzhou 646000, Sichuan, China.
Publication Type:Journal Article
Keywords: CRISPR/Cas9; MPC5 cells; Smad3; gene knockout
MeSH: Animals; Smad3 Protein/genetics*; CRISPR-Cas Systems/genetics*; Mice; Podocytes/metabolism*; Transforming Growth Factor beta1/pharmacology*; Cell Line; Gene Knockout Techniques; RNA, Guide, CRISPR-Cas Systems/genetics*
From: Chinese Journal of Biotechnology 2025;41(4):1658-1670
CountryChina
Language:Chinese
Abstract: This study established the mouse podocyte clone-5 (MPC5) with Smad3 knockout and studied the effect of transforming growth factor-beta 1 (TGF-β1) on the dedifferentiation of the MPC5 cells with Smad3 knockout, aiming to provide a cell tool for studying the role of Smad3 in mouse podocytes. The single-guide RNA (sgRNA) sequence targeting Smad3 was designed according to the principles of CRISPR/Cas9 design. The pX458-Smad3 vector was constructed and introduced into competent cells, and then the vector was extracted and used to transfect MPC5 cells. The successfully transfected cells were sorted by a flow cytometer. After single-cell clone expansion, PCR amplification of sequences adjacent to the edition site of Smad3 and sequencing were performed to identify potential cells with gene knockout. Western blotting was employed to verify the knockout efficiency of Smad3. Finally, the effect of Smad3 knockout on TGF-β1-induced dedifferentiation of MPC5 cells was analyzed by reverse transcription-polymerase chain reacting (RT-PCR), Western blotting, and the immunofluorescence method. The sgRNA was designed to target the fifth exon of Smad3. EGFP expression was observed 24 h after transfection of the pX458-Smad3 plasmid into MPC5 cells, with the transfection efficiency of 0.1% as determined by flow cytometry. From the transfected cells, 21 cell clones were obtained through flow cytometric sorting and single-cell clone expansion. PCR amplification and sequencing of the region around the sgRNA target site in Smad3 identified two cell clones with biallelic frameshift mutations. Western blotting results confirmed the absence of Smad3 expression in these clones, indicating successful establishment of the MPC5 cell line with Smad3 knockout. In normal MPC5 cells, TGF-β1 stimulation promoted the expression of fibrosis-related genes fibronectin and Col1a1 (collagen I) and inhibited the expression of the podocyte marker proteins synaptopodin and podocin, which suggested epithelial-mesenchymal transition and podocyte injury. However, in the two MPC5 cell lines with Smad3 knockout, TGF-β1-induced expression of epithelial-mesenchymal transition markers was significantly suppressed. The MPC5 cell lines with Smad3 knockout that were constructed by CRISPR/Cas9 provide a valuable cell model for functional studies of Smad3 protein and highlight the critical role of Smad3 in cell dedifferentiation.